Miguel Moreno
Nanyang Technological University, Singapore
Biography
Miguel Moreno has a passionate interest in drug delivery and innovation management. He really looks forward to transferring his research to commercially feasible technology. He is a committed biomedical research scientist with over fifteen years’ experience in biophysics (protein-protein and protein-liposome interactions), biochemistry, polymer chemistry, drug delivery systems, sustained release, biomedical applications. He has developed a polymer-based platform for carrying peptides, bringing out a targeted pro-cytotoxic drug delivery system based on wasp venom for cancer therapy, which has been awarded. At present, he is involved in a large "ocular diseases" project, from NTU-Northwestern Institute for Nanomedicine (NNIN), for developing new carriers to deliver anti-inflamatory drugs and anti-VEGF proteins for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). He has expertise in designing, optimizing and evaluating entrapment of therapeutic proteins, peptides and small molecules into a wide variety of nano- and microcarriers and hydrogels.